Lee, Hyemin
Zandkarimi, Fereshteh
Zhang, Yilei http://orcid.org/0000-0003-1407-0301
Meena, Jitendra Kumar http://orcid.org/0000-0003-0199-9357
Kim, Jongchan
Zhuang, Li
Tyagi, Siddhartha
Ma, Li http://orcid.org/0000-0001-9965-989X
Westbrook, Thomas F.
Steinberg, Gregory R. http://orcid.org/0000-0001-5425-8275
Nakada, Daisuke http://orcid.org/0000-0001-6010-7094
Stockwell, Brent R. http://orcid.org/0000-0002-3532-3868
Gan, Boyi http://orcid.org/0000-0001-8884-6040
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA181196)
Article History
Received: 28 May 2019
Accepted: 3 January 2020
First Online: 6 February 2020
Competing interests
: B.R.S. holds equity in and serves as a consultant to Inzen Therapeutics and is an inventor on patents and patent applications related to ferroptosis. The other authors declare no competing financial interests.